| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HERV-H LTR-associating 1 | 1.000 | 0.038 | 2.9E-14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
chronic lymphocytic leukemia up-regulated 1 | 1.000 | 0.115 | 1.7E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
zinc finger protein 382 | 0.760 | 0.192 | 2.9E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 1994 | 1998 | |||||||||
|
T cell receptor delta joining 1 | 0.736 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor delta diversity 3 | 0.736 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
T cell receptor delta constant | 0.729 | 0.269 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 1999 | 2003 | |||||||||
|
PAS domain containing repressor 1 | 0.780 | 0.269 | 0.82 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ubiquitin specific peptidase 9 Y-linked | 0.743 | 0.269 | 5.7E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
apoptotic chromatin condensation inducer 1 | 0.751 | 0.308 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
LETM1 domain containing 1 | 0.682 | 0.308 | 4.9E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
elongation factor for RNA polymerase II | 0.700 | 0.308 | 0.99 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
sperm associated antigen 6 | 0.769 | 0.308 | 1.3E-13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
C-type lectin domain family 12 member A | 0.686 | 0.346 | 2.6E-07 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2018 | ||||||||
|
chromosome 16 open reading frame 82 | 0.743 | 0.346 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
NUT midline carcinoma family member 1 | 0.612 | 0.346 | 2.4E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
MLLT1 super elongation complex subunit | 0.663 | 0.346 | 0.99 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
solute carrier family 13 member 2 | 0.736 | 0.346 | 1.3E-13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
T cell receptor gamma constant 1 | 0.663 | 0.385 |
|
phenotype | 0.090 | None | 0.889 | 9 | 0 | 1998 | 2012 | |||||||||
|
calcium voltage-gated channel auxiliary subunit gamma 2 | 0.729 | 0.385 | 0.92 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2001 | 2014 | ||||||||
|
BAALC binder of MAP3K1 and KLF4 | 0.631 | 0.385 | 4.4E-03 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2016 | ||||||||
|
P2Y receptor family member 8 | 0.700 | 0.385 | 3.4E-03 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2018 | ||||||||
|
transcription factor Dp family member 3 | 0.751 | 0.385 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
Ras association domain family member 10 | 0.626 | 0.385 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
nucleoporin 214 | 0.638 | 0.385 | 5.5E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 |